CN Patent

CN105073749A — 制备利拉利汀的改进方法

Assigned to Mylan Laboratories Ltd · Expires 2015-11-18 · 10y expired

What this patent protects

本发明涉及通过纯化中间体化合物、将纯化的中间体转化成利拉利汀从而制备利拉利汀的方法。本发明还涉及无定形利拉利汀的制备。

USPTO Abstract

本发明涉及通过纯化中间体化合物、将纯化的中间体转化成利拉利汀从而制备利拉利汀的方法。本发明还涉及无定形利拉利汀的制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN105073749A
Jurisdiction
CN
Classification
—
Expires
2015-11-18
Drug substance claim
No
Drug product claim
No
Assignee
Mylan Laboratories Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.